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Abstract: Myomectomy is the main conservative uterine operation of modern gynecology, as the percentage of patient 
with myomas is ever increasing. In the last century, this operation was performed by “open” technique, then, with the 
advent of minimally invasive technologies, it is passed to the endoscopic method. Thus, hysteroscopy and laparoscopy, 
until the modern robotically assisted surgery were introduced or the removal of uterine myomas. Many of the concepts of 
traditional surgery, in light of modern scientific evidences, were revisited, since the myomectomy have been evaluated 
from the morphological-functional side. Therefore, with the forthcoming endocrinal biological discoveries, myomectomy 
has slowly changed the technical and surgical planning. Many limits have been widely surpassed, up to the possibility of 
applying this method even in older women, over 45 in which is critical of the uterus preservation for assisted procreation. 
In the last century, considering to perform a myomectomy in a 45-47 year old woman with myomas was an unlikely 
thought; nowadays, with the methods of assisted reproductive technique, many reproductive limits have been largely 
overcome, until the menopausal pregnancy. This clinical opinion is based on biologic anatomic morphological evidences, 
which allowed knowing better the consequences of uterine myomectomy within the capabilities of the uterus after 
myomectomy. 
Keywords: Myoma, Fibroid, Myomectomy, Laparoscopy, Robotic, Myoma pseudocapsule, Neurovascular bundle, 
Cesarean myomectomy, Pregnancy, Complication, Uterine rupture. 
INTRODUCTION 
Uterine myomectomy is a surgical technique that 
has evolved over the years, with the improvement of 
technology and surgical methods. Much progress has 
been made in the field of minimally invasive surgery, 
but still many steps will have to improve patients’ 
surgical outcome after myomectomy. Myoma is the 
most common gynecological disease, compromising 
the uterine reproductive function and causing many 
troublesome symptoms. The uterus, for its uniqueness, 
must be always spared, especially in case of intramural 
and subserosal myomas, to avoid the definitive loss of 
reproductive chances. Moreover, the increasing age of 
first pregnancy, presupposes to face with myomas in 
pregnancy with greater frequency, as well as the ability 
to perform myomectomy also over 40-45 years, in 
order to preserve the organ for an assisted 
reproductive technique (ART). If in the past, patients 
with fibroids over forty-five years’ had few chances to 
become pregnant, now many women remain pregnant 
after ART, even in menopause, over fifty. This socio-
demographic changesled the ethical and deontological  
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problem of conservative surgery over forty-five years. 
Fibromatous uterus removal at 45 years’, nowadays, 
could create a subsequent medical legal litigation, 
since the ART gives good chances of pregnancy 
(Figure 1), even after 50’ years. 
 
Figure 1: An ultrasonographic scan of a pregnant of 43 
years’ old at 9 weeks with a 5 cm myoma. 
ANATOMIC FINDINGS: BASIC CONCEPTS 
Myomaor fibroid may be either solitary or multiple, 
demonstrates three distinctive growth patterns, 
according to their anatomical localization. They may be 
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intramural (localized within the myometrium), 
subserous (externally positioned, extending to the 
serosa), submucous (protruding into uterine cavity) and 
pedunculated, extending through cervical canal or into 
abdominal cavity. Intramural fibroids are the most 
common myoma type, followed by subserous fibroids. 
Submucosal fibroids occur least frequently, although 
they often cause symptoms at a very early stage. 
Subserous and submucosal fibroids can also be 
pedunculated [1].  
The myometrium is predominantly made of smooth 
muscle cells surrounded by a rich network of blood and 
lymphatic vessels and fibroid are benign neoplasms 
that arise into myometrium. They are composed of 
disordered fascicles of smooth muscle cells with 
variable amount of fibrous tissue. During its growth, 
myoma compresses the surrounding tissue, causing 
formation of a pseudocapsule, encapsulating the 
myoma (Figure 2) [2].  
 
Figure 2: An ultrasonographic scan of intramural myoma in 
trapezoidal area, surrounded by a white ring, the 
pseudocapsule. 
The mechanical properties of myomas are a key 
factor that can contribute to their growth. While 
myomas are more rigid, pseudocapsule is more elastic, 
due to lower content of extracellular matrix, which 
allows uterine adaptation to the myoma growth. Hence, 
myoma induces displacement on the peripheral 
myometrium by its growth, without destructive action, 
since the integrity and contractility of uterine structure 
is maintained [3].  
Biological genesis of the pseudocapsule is not well 
known yet, although literature data have documented 
that the pseudocapsule originates from myometrium 
surrounding myoma [2]. So far, it appears to be a 
myometrium protective structure possibly enhancing 
regenerative mechanisms [4]. 
Fox et al. [4], investigated myoma specimens by 
means of ultrastructural microscopy. Those researches 
found an anatomical structure distinct from normal 
myometrium, asserting that myomas have a clear 
outline and forming a pseudocapsule made of 
compressed muscle fibers, which surrounds myomas. 
Malvasi et al. [5] investigated the ultrastructural 
features of subserous and intramural myomas using 
visualization by transmission electron microscopy. The 
authors described the fine ultrastructural details of the 
pseudocapsule cells, which showed the features of 
smooth muscle cells similar to the myometrium. This 
confirmed the concept that the pseudocapsule is part of 
the myometrium compressed by the myoma [2].  
Ito et al. [6] performed a histopathology evaluation 
of the myoma and its pseudocapsule. By 
microstructural studies of the architecture of the 
myometrium and the extra-cellular matrix in the 
presence of myomas. Authors found that the myoma is 
anchored to the pseudocapsule by connective bridges, 
but lacks its own true vascular pedicle. This is one of 
the main mistakes made by surgeons when they seek 
the vascular pedicle. Not only the vascular pedicle 
does not exist, but also it is useless to try to find it in 
the myometrium as obviously wrong surgical technique. 
When myomectomyis started, it must hit its target to 
achieve the cleavage plane between myoma and 
myometrium, to preserve either tissue surrounding 
fibroid or scar formation, with positive impact on 
reproductive outcome [7]. 
This clinical opinion focuses on intramural and 
subserosal myomas, where is necessary to operate 
directly on the uterus, incising the serosa and 
myometrium. 
Step 1: Hysterotomy and Myoma Enucleation 
The first step of myomectomy is the visceral 
peritoneum incision, followed by hysterotomy to arrive 
to myoma, highlighting the cleavage plane between 
myoma and myometrium, the pseudocapsule (Figures 
3 A and B). This passage is the most delicate of the 
operation and it should be done quickly, with 
appropriateness and safety. Myomectomy should be by 
intracapsular method, using the physio pathological 
concepts and solutions in cleavage plane interception, 
to avoid bleeding (Figures 4 A-C). 
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All surgeons should always avoid, for example, to 
open the fibroid in two part and use the myoma surface 
to dissect myoma from its pseudocapsule, to better 
spare it. It only massively bleeds. 
         
    (A)       (B) 
Figures 3 A and B: Laparoscopic myomectomy. The first step of intramural / subserosal myomectomy is the visceral 
peritoneum incision, followed by hysterotomy to arrive to myoma (A), highlighting the cleavage plane between myoma and 
myometrium, the pseudocapsule (B). 
         
    (a)       (b) 
      
        (c) 
Figures 4 A-C: Laparoscopic myomectomy should be by intracapsular method: a) clamping myoma by hook or clamps; b) 
cutting the fibro-vascular connective pseudocapsule bridges, which anchor myoma to myometrium; c) exposing in a manner as 
detailed as possible the myoma for its enucleation. 
14    International Journal of Gynecology, Obstetrics and Neonatal Care, 2017, Vol. 4, No. 1 Andrea Tinelli 
The technique of modern laparoscopic, robotic or 
laparotomic myomectomy is similar to shish kebab 
cutting or orange peel cleaning, gently removing the 
filaments from the beans. 
In this way, the surgeon selectively coagulates all 
the small vessels that are contained in pseudocapsule 
and that vascularize the fibroids (Figures 5 A-D). The 
surgeon progressively cut off the surface in contact 
with the myoma, cutting only the fibrovascular bundle 
surrounding myoma, enucleating the myoma from the 
myometrium, as safely and less bleeding as possible 
[8]. 
Step 2: Hysterorraphy 
Suturing of myometrium after myomectomy has 
always been thought as a very complex surgical 
problem. On the contrary, it always falls within the 
concept of anatomical myometrium, myoma and 
pseudocapsule. After removal of the myoma (in the 
manner described above), by the intracapsular 
myomectomy [9], the myometrium should not bleed 
excessively. 
After myoma enucleating sparing pseudocapsule, 
surgeon should perform an adequate hysterorraphy 
(Figure 6), following some basic concepts: 
• Myometrial suturing should be with shrewdness, 
to avoid the large myoma fovea spaces and 
blood collection inside (damaging the healing 
process). 
• Not too many stitches on myometrium, since it 
should be nota hemostatic suture, but a plastic 
suture (as in case of ovarian suturing after 
ovarian endometrioma removal, where it needs 
         
    (A)       (B) 
         
    (C)       (D) 
Figures 5 A-D: Once surgeon find the cleavage plane between myoma and myometrium, the pseudocapsule, myoma should 
be enucleated by a similar method to shish kebab cutting or orange peel cleaning, as gently removing the filaments from the 
beans. Surgeon selectively coagulates all the small vessels (fibro-vascular connective pseudocapsule bridges) contained in 
pseudocapsule, that vascularize the fibroids and anchors it to myometrium. 
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to be spared the functional ovarian tissue and 
follicles). 
• The stiches can be of many kinds (conventional, 
monofilament, braided wires, barbed) but they 
should be adequately applied without excessive 
force in tie, avoiding: tissue ischemia, hypoxia, 
necrosis and intramuscular foreign body 
reaction.  
• By physiological CO2 effects, after some 
minutes later on uterine myorraphy, the 
functional bleeding of the incised visceral 
peritoneum stops also for the CO2 pro-coagulant 
effect [8]. 
• It should be avoided drains into pelvis after 
myomectomy (ineffective and harmful for post-
operative adhesions) [10] 
The same passages are suggested also in 
cesarean myomectomy, since it was already proved its 
efficacy in literature by a surgical trial [2]. 
BLEEDING PROBLEMS DURING MYOMECTOMY: 
HOW TO SOLVE THEM? 
Generally, the achievement of the fibrovascular 
bundle of pseudocapsule surface is quite easy in every 
myomectomy. Upon reaching the myomasurface after 
hysterotomy, the surgeon catches myoma by surgical 
clamp and pull the myoma outside its fovea, in order to 
expose the fibrovascular bundle to selectively 
coagulate and cut (Figure 7). During this maneuver, 
surgeon does not need to stop the vascular flow to 
myometrium to reduce bleeding during myoma 
enucleation. The uterine stop flow could lead to a 
potential risk of myometrial/endometrial ischemia. 
 
Figure 7: To avoid excessive bleeding, surgeon pulls the 
myoma outside its fovea, in order to expose the fibrovascular 
bundles to gently and selectively coagulate and cut them. 
On the contrary, because of progressive clotting 
during myoma enucleation, focused on pseudocapsule 
gentle sparing (Figure 8), it is very important to avoid 
two popular maneuvers among surgeons:  
1) the temporary occlusion of uterine artery by 
clamps; 
2) the use of vasopressin into myometrium injection 
before myomectomy. 
Both are not useful and even harmful for the correct 
healing of myometrium, basing on myoma/ 
myometrialanatomy described below. 
         
    (A)       (B) 
Figures 6 A and B: Hysterorraphy after intracapsular myomectomy. Myometrial suturing should be avoiding the 
myometrialempty spaces with blood collection inside, avoiding too many stitches on myometrium, and they should be 
adequately applied without excessive force in tie, avoiding: tissue ischemia, hypoxia, necrosis and intramuscular foreign body 
reaction. 
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Figure 8: Laparoscopic intracapsular myomectomy by gentle 
pseudocapsule sparing during myoma enucleation. 
Anotherproblem of myometrium temporary 
devascularization by stop flow is that it could mask the 
successive bleeding from temporarily collapsed vessels 
(by uterine artery occlusion or vasopressin injection). 
Following these anatomical surgical concepts, a 
correct modern myomectomy should be performed as 
in cardiovascular surgery (contemporary to hearth 
beating), without the uterine routine temporary stop-
flow, to avoid: 
• To mask the fibrovascular cleavage plane [8] 
• The collateral pharmacological side effects of 
vasopressin injection on patient’ cardiovascular 
system [7] 
• The possible unexpected postoperative bleeding 
from scar, after myometrial revascularization 
(that could leads to post-surgical adhesions) 
• The lack of scientific evidence on efficacy of the 
temporary occlusion of uterine artery or use of 
vasopressin injection [11] on 
myometrial/endometrial wellbeing.  
Occasionally, during the enucleation of deep 
intramural fibroids, it can happen that the bleeding is 
excessive because of the myometrial layer to cross 
during myoma achievement. This happens especially in 
case of deep intramural myoma of small volume. Only 
in such cases, it is reasonable to use the temporary 
occlusion of uterine artery by clamps or use of 
vasopressin, to reduce the bleeding prior to enucleate 
the myoma. 
CONTROVERSIES ON LEIOMYOSARCOMA MISS-
DIAGNOSIS PRIOR MYOMECTOMY  
Some studies reviewed the risk of occult uterine 
leiomyosarcoma, during surgery for presumed benign 
fibroids. The prevalence of leiomyosarcoma is 10-fold 
higher in women older than age 60 years when 
compared with women younger than age 50 years [12]. 
Bojahr et al reported two occult leiomyosarcoma 
among 8,720 women having surgery for leiomyomas 
(0.023%), and reported a prevalence of 2 of 8,720 
(0.023%) [13], while Parker et al. reported prevalence 
of 1 in 1,960 (0.051%) with the randomized controlled 
trials having a prevalence of 0 [14]. Comparing data, 
the reanalyzed FDA data set yielded a prevalence of 1 
in 1,550 (0.064%), while Pritts investigation reported a 
prevalence of 1 in 1,960 (0.051%) with the randomized 
controlled trials having a prevalence of 0, and the 
Bojahr study reported a prevalence of 2 of 8,720 
(0.023%).By these data therefore, it is clear that we are 
in the presence of a very rare event. Moreover, even if 
leiomyosarcoma was removed intact without 
morcellation, it has always a poor prognosis. Parker  
et al. l [14], basing on oncological Surveillance, 
Epidemiology, and End Results data, reported that the 
5-year survival of stage I and II leiomyosarcoma was 
only 61%.  
Whether morcellation influences the prognosis of 
women with leiomyosarcoma is not known and the 
biology of this tumor has not been well understand. 
Distant metastasis occurs early in the disease process, 
primarily by hematogenous dissemination. Four quoted 
published studies examined patients’ survival after 
power morcellation. Surprisingly, virtually none of the 
women in these studies had power morcellation. 
Furthermore, the data presented in these studies have 
been slightly analyzed and patients’ cohorts were very 
few. The only scientific dogma is that no scientifically 
reliable method to significantly differentiate, 
preoperatively, a leiomyoma from a leiomyosarcoma 
exists (Figure 9) [14]. 
The proposal methods to investigate, in 
preoperative set, the leiomyoma characteristics were: 
a) Dynamic MRI with serum measurement of lactate 
dehydrogenase (LDH-3) levels;  
b) Gadolinium injection in vein, at the time of the 
MRI, seeing RMN slides 40-60 seconds after injection, 
and, if a sarcoma is suspected, the dye will light up the 
mass on the MRI;  
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c) The F-fluorodeoxyglucose positron emission 
tomography [15]. 
 
Figure 9: Ultrasonographic evaluation of a myoma in necrotic 
degeneration. 
With these methods, yet under investigation, in the 
near future, medicine will be able to highlight deserving 
cases of clinical diagnostic investigation for suspected 
leiomyosarcoma. On the contrary, the definitive 
diagnosis of leiomyosarcoma is currently only by 
histology [16]. 
An increasing incidence of leiomyosarcoma was 
observed in patients: 
a) Over 45 years;  
b) Women treated by Tamoxiphen;  
c) Patients treated by Radiotherapy [14].  
In these selected patients, the incidence on 
leiomyosarcoma is increased comparing with other 
patients, in which the biology of the leiomyoma is 
completely different from leiomyoma, as they have a 
different biological characterization. Generally, 
leiomyosarcoma arises from a new cell clone different 
from the cell clone of leiomyoma; leiomyosarcoma 
born, thus, "de novo" and it does not originate in a 
leiomyoma. Finally, the myoma always has a 
pseudocapsule (detected by ultrasonographic Doppler 
scan, as a “ring of fire”) (Figure 10) [17], but the 
leiomyosarcoma notroutinely [18]. 
DOUBTS ON SAFENESS OF “IN BAG” 
MORCELLATION TO AVOID A POSSIBLE 
LEIOMYOSARCOMA SPREADING 
From the beginning of its use, laparoscopic-aided 
morcellation allowed the surgeon to inspect the pelvic 
and abdominal cavities and to irrigate and to remove 
tissue fragments under visual magnification. On the 
contrary, the surgeon cannot visually inspect the 
peritoneal cavity during vaginal or minilaparotomy 
procedures. Morcellation within containment bags has 
recently been used in an attempt to avoid spread of 
tissue. These methods have not yet been proven 
effective or safe, and there is concern that bags may 
make morcellation more cumbersome and less safe.  
There are no scientific studies showing that the use 
of the bag in myoma morcellation:  
1. can improve the prognosis of leiomyosarcoma, 
can reduce the risk cancer spreading (when 
coring tumor from the uterus); 
2. can lead to a reduction staging compared to 
morcellation out of bags, when surgeon coring 
the “cancer mass” from uterus. 
             
    (A)       (B) 
Figures 10 A and B: Myoma always has a pseudocapsule, detected by ultrasonographic Doppler scan, as a “ring of fire”. 
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At this point, thinking about the scientific data, we 
could make a comparison between two clinical 
unsolved problems: the use of the "in bag morcellation" 
to reduce undiagnosed leiomyosarcoma during 
myomectomy and the use of caesarean section to 
avoid a possible risk of shoulder dystocia. Given the 
absolute low rate of leiomyosarcoma after 
myomectomy, the problem of unnecessary “in bag” 
myoma morcellationfor the hypothetic risk of occulted 
leiomyosarcoma could be compared to a famous 
obstetric study. Rouse et al. [19] examined the cost-
effectiveness of a caesarean delivery to reduce 
shoulder dystocia risk, for suspected macrosomia in 
nondiabetic mothers with estimated weight greater than 
4,500 grams: They concluded that, in order to prevent 
JUST ONE case of permanent brachial plexus injury, 
3,695 caesarean sections would need to be performed 
(at a cost of US$8.7 million) [19]. If we think to both 
these supposed risks and the related costs of time and 
surgery, we could be more realistic in our daily surgery. 
In fact, the “in bag” morcellation, recommended by 
many surgeons to reduce an hypothetic risk of 
leiomyosarcoma spreading after myomectomy leaded 
to:  
a) Unjustified increase of the times of laparoscopy 
and robotics, against hypothetical benefits that the bag 
can support (time consuming);  
b) An unjustified increase of the possible 
complications during in bag morcellation, as additive 
scientifically untested surgical time, to an overall 
increase of the intervention costs (bags and times). 
One final thought is on myoma fragments spreading 
during morcellation. These fragments may be the 
cause of the parasitic leiomyomas (Figure 11), 
probably related to the incorrect myomectomy 
technique. If leiomyoma is removed from the uterus 
with part of the pseudocapsule on its surface during 
fibroid morcellation, adequate caution should be 
exercised to remove all myoma fragments. Myoma 
pseudocapsule has a proper very active angiogenesis 
[20] and the myoma fragments surrounded by 
pseudocapsule could attach the peritoneal surface 
during morcellation, the muscle or other organs. It 
could create, by its own angiogenesis, the maintenance 
and growth of myoma at the implantation site, so called 
the parasitic leiomyomas. This could be the real benefit 
of the “in bag” morcellation after myomectomy. 
 
Figure 11: Ad abdominal ultrasonographic scan showing a 
parasitic leiomyoma near the oblique muscle of the rectus, 
where it had been positioned the ancillary trocar. 
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